BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 1381199)

  • 1. Identification of a small epitope in domain Ib of Pseudomonas aeruginosa exotoxin A that elicits enzyme-neutralizing antibodies.
    Rutault K; Coin D; Vacheron MJ; Guinand M; Wallach J; Michel G
    FEMS Microbiol Immunol; 1992 Jul; 4(5):267-72. PubMed ID: 1381199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of neutralizing antipeptide antibodies to the enzymatic domain of Pseudomonas aeruginosa exotoxin A.
    Elzaim HS; Chopra AK; Peterson JW; Goodheart R; Heggers JP
    Infect Immun; 1998 May; 66(5):2170-9. PubMed ID: 9573104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative immunochemistry of two fragments from domains Ib and III of Pseudomonas aeruginosa exotoxin A.
    Rutault K; Vacheron MJ; Guinand M; Michel G
    Infect Immun; 1993 Dec; 61(12):5417-20. PubMed ID: 8225617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of synthetic peptides and site-specific antibodies to localize a diphtheria toxin sequence associated with ADP-ribosyltransferase activity.
    Olson JC
    J Bacteriol; 1993 Feb; 175(3):898-901. PubMed ID: 8423159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Pseudomonas aeruginosa alginate-exotoxin A conjugate that elicits anti-alginate and exotoxin A-neutralizing antibodies.
    Coin D; Vacheron MJ; Guinand M; Michel G
    FEMS Microbiol Immunol; 1991 Aug; 3(4):185-92. PubMed ID: 1931130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of functional epitopes of Pseudomonas aeruginosa exotoxin A using synthetic peptides and subclone products.
    Olson JC; Hamood AN; Vincent TS; Beachey EH; Iglewski BH
    Mol Immunol; 1990 Oct; 27(10):981-93. PubMed ID: 1700288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and immunochemical studies of proteolytic fragments of exotoxin A from Pseudomonas aeruginosa.
    Bourdenet S; Vacheron MJ; Guinand M; Michel G; Arminjon F
    Eur J Biochem; 1990 Sep; 192(2):379-85. PubMed ID: 2170123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Protective polysaccharide-protein artificial antigens from O-specific polysaccharides of Pseudomonas aeruginosa and its exotoxin A].
    Dmitriev BA; Kul'shin VA; Antsiferova NG; Vovk VA; Moroz AF
    Dokl Akad Nauk SSSR; 1988; 298(5):1277-80. PubMed ID: 2454182
    [No Abstract]   [Full Text] [Related]  

  • 9. A nontoxic Pseudomonas exotoxin A induces active immunity and passive protective antibody against Pseudomonas exotoxin A intoxication.
    Chen TY; Lin CP; Loa CC; Chen TL; Shang HF; Hwang J; Hui CF
    J Biomed Sci; 1999; 6(5):357-63. PubMed ID: 10494043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of monoclonal antibody specific for domain Ia/II of Pseudomonas aeruginosa exotoxin A at pH 4 strongly neutralizes exotoxin A-induced cytotoxicity in cell culture and in vivo.
    Ohtsuka H; Horigome K; Higuchi A; Nomura N; Ochi H; Yokota S; Kohzuki T; Noguchi H
    Infect Immun; 1992 Mar; 60(3):1061-8. PubMed ID: 1371763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A macromolecular structure produced by Pseudomonas aeruginosa is recognized by antibody to exotoxin A.
    Klinger KW; Shuster CW
    Infect Immun; 1984 Mar; 43(3):912-9. PubMed ID: 6421741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primate antibody response to immunotoxin: serological and computer-aided analysis of epitopes on a truncated form of Pseudomonas exotoxin.
    Roscoe DM; Jung SH; Benhar I; Pai L; Lee BK; Pastan I
    Infect Immun; 1994 Nov; 62(11):5055-65. PubMed ID: 7927788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of epitopes on a mutant form of Pseudomonas exotoxin using serum from humans treated with Pseudomonas exotoxin containing immunotoxins.
    Roscoe DM; Pai LH; Pastan I
    Eur J Immunol; 1997 Jun; 27(6):1459-68. PubMed ID: 9209499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production and characterization of human monoclonal antibody recognizing the N-terminal residues of Pseudomonas aeruginosa exotoxin A.
    Ohtsuka H; Horigome K; Ochi H; Nishimoto T; Kozuki T; Kato M; Okuda T; Noguchi H
    Hybridoma; 1991 Apr; 10(2):297-307. PubMed ID: 1651902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody titers in serum of diffuse panbronchiolitis patients administered a multicomponent Pseudomonas aeruginosa vaccine consisting of toxoids of protease, elastase and exotoxin A and a common protective antigen (OEP).
    Yamamoto M; Kubota Y; Matsuura M; Homma JY
    Kitasato Arch Exp Med; 1988 Sep; 61(2-3):127-35. PubMed ID: 3145352
    [No Abstract]   [Full Text] [Related]  

  • 16. [Production of an diagnostic erythrocyte agent from Pseudomonas aeruginosa exotoxin A].
    Egizova SA; Deriabin PN; Karal'nik BV; Kanapina ASh; Moroz AF
    Zh Mikrobiol Epidemiol Immunobiol; 1988 Dec; (12):38-41. PubMed ID: 3149841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteolytic cleavage of exotoxin A from Pseudomonas aeruginosa: formation of an ADP-ribosyltransferase active fragment by the action of Pseudomonas elastase.
    Sanai Y; Morihara K; Tsuzuki H; Homma JY; Kato I
    FEBS Lett; 1980 Oct; 120(1):131-4. PubMed ID: 6254804
    [No Abstract]   [Full Text] [Related]  

  • 18. Diphtheria toxin and Pseudomonas aeruginosa exotoxin A: active-site structure and enzymic mechanism.
    Wilson BA; Collier RJ
    Curr Top Microbiol Immunol; 1992; 175():27-41. PubMed ID: 1628498
    [No Abstract]   [Full Text] [Related]  

  • 19. Toxoids of Pseudomonas aeruginosa exotoxin-A: photoaffinity inactivation of purified toxin and purified toxin derivatives.
    Callahan LT; Martinez D; Marburg S; Tolman RL; Galloway DR
    Infect Immun; 1984 Mar; 43(3):1019-26. PubMed ID: 6321348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and genetic aspects of Pseudomonas aeruginosa virulence.
    Lory S; Tai PC
    Curr Top Microbiol Immunol; 1985; 118():53-69. PubMed ID: 2414071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.